| UniProt ID | CIP2A_HUMAN | |
|---|---|---|
| UniProt AC | Q8TCG1 | |
| Protein Name | Protein CIP2A {ECO:0000305} | |
| Gene Name | CIP2A {ECO:0000312|HGNC:HGNC:29302} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 905 | |
| Subcellular Localization |
Membrane Single-pass membrane protein . Cytoplasm . Slightly concentrates in the perinuclear region (PubMed:12118381). |
|
| Protein Description | Oncoprotein that inhibits PP2A and stabilizes MYC in human malignancies. Promotes anchorage-independent cell growth and tumor formation.. | |
| Protein Sequence | MDSTACLKSLLLTVSQYKAVKSEANATQLLRHLEVISGQKLTRLFTSNQILTSECLSCLVELLEDPNISASLILSIIGLLSQLAVDIETRDCLQNTYNLNSVLAGVVCRSSHTDSVFLQCIQLLQKLTYNVKIFYSGANIDELITFLIDHIQSSEDELKMPCLGLLANLCRHNLSVQTHIKTLSNVKSFYRTLITLLAHSSLTVVVFALSILSSLTLNEEVGEKLFHARNIHQTFQLIFNILINGDGTLTRKYSVDLLMDLLKNPKIADYLTRYEHFSSCLHQVLGLLNGKDPDSSSKVLELLLAFCSVTQLRHMLTQMMFEQSPPGSATLGSHTKCLEPTVALLRWLSQPLDGSENCSVLALELFKEIFEDVIDAANCSSADRFVTLLLPTILDQLQFTEQNLDEALTRKKCERIAKAIEVLLTLCGDDTLKMHIAKILTTVKCTTLIEQQFTYGKIDLGFGTKVADSELCKLAADVILKTLDLINKLKPLVPGMEVSFYKILQDPRLITPLAFALTSDNREQVQSGLRILLEAAPLPDFPALVLGESIAANNAYRQQETEHIPRKMPWQSSNHSFPTSIKCLTPHLKDGVPGLNIEELIEKLQSGMVVKDQICDVRISDIMDVYEMKLSTLASKESRLQDLLETKALALAQADRLIAQHRCQRTQAETEARTLASMLREVERKNEELSVLLKAQQVESERAQSDIEHLFQHNRKLESVAEEHEILTKSYMELLQRNESTEKKNKDLQITCDSLNKQIETVKKLNESLKEQNEKSIAQLIEKEEQRKEVQNQLVDREHKLANLHQKTKVQEEKIKTLQKEREDKEETIDILRKELSRTEQIRKELSIKASSLEVQKAQLEGRLEEKESLVKLQQEELNKHSHMIAMIHSLSGGKINPETVNLSI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDSTACLK -------CCHHHHHH | 9.18 | 19413330 | |
| 3 | Phosphorylation | -----MDSTACLKSL -----CCHHHHHHHH | 19.33 | 30631047 | |
| 4 | Phosphorylation | ----MDSTACLKSLL ----CCHHHHHHHHH | 19.68 | 30631047 | |
| 8 | Ubiquitination | MDSTACLKSLLLTVS CCHHHHHHHHHHHHH | 38.65 | - | |
| 9 | Phosphorylation | DSTACLKSLLLTVSQ CHHHHHHHHHHHHHH | 15.99 | 21406692 | |
| 13 | Phosphorylation | CLKSLLLTVSQYKAV HHHHHHHHHHHHHHH | 20.34 | 21406692 | |
| 15 | Phosphorylation | KSLLLTVSQYKAVKS HHHHHHHHHHHHHHC | 23.66 | 21406692 | |
| 17 | Phosphorylation | LLLTVSQYKAVKSEA HHHHHHHHHHHHCCC | 8.07 | 21406692 | |
| 18 | Ubiquitination | LLTVSQYKAVKSEAN HHHHHHHHHHHCCCC | 38.78 | 29967540 | |
| 21 | Acetylation | VSQYKAVKSEANATQ HHHHHHHHCCCCHHH | 47.65 | 25953088 | |
| 21 | Ubiquitination | VSQYKAVKSEANATQ HHHHHHHHCCCCHHH | 47.65 | 27667366 | |
| 40 | Malonylation | LEVISGQKLTRLFTS HHHHCCCCHHHHHCC | 56.18 | 26320211 | |
| 40 (in isoform 1) | Ubiquitination | - | 56.18 | 21906983 | |
| 40 | Ubiquitination | LEVISGQKLTRLFTS HHHHCCCCHHHHHCC | 56.18 | 27667366 | |
| 40 | Acetylation | LEVISGQKLTRLFTS HHHHCCCCHHHHHCC | 56.18 | 23236377 | |
| 92 | S-nitrosylation | VDIETRDCLQNTYNL CCCCHHHHHHHCCCC | 3.67 | 19483679 | |
| 92 | S-nitrosocysteine | VDIETRDCLQNTYNL CCCCHHHHHHHCCCC | 3.67 | - | |
| 108 | S-nitrosylation | SVLAGVVCRSSHTDS HHHHHHHHCCCCCCH | 3.03 | 19483679 | |
| 108 | S-nitrosocysteine | SVLAGVVCRSSHTDS HHHHHHHHCCCCCCH | 3.03 | - | |
| 234 | Phosphorylation | HARNIHQTFQLIFNI HHCCHHHHHHHHHHH | 10.13 | - | |
| 248 | Phosphorylation | ILINGDGTLTRKYSV HHHCCCCCCCEEHHH | 29.69 | - | |
| 250 | Phosphorylation | INGDGTLTRKYSVDL HCCCCCCCEEHHHHH | 25.59 | - | |
| 253 | Phosphorylation | DGTLTRKYSVDLLMD CCCCCEEHHHHHHHH | 15.61 | - | |
| 275 | Ubiquitination | ADYLTRYEHFSSCLH HHHHHHHHHHHHHHH | 34.86 | 22505724 | |
| 297 | Ubiquitination | GKDPDSSSKVLELLL CCCCCCHHHHHHHHH | 30.64 | 22505724 | |
| 315 | Ubiquitination | SVTQLRHMLTQMMFE HHHHHHHHHHHHHHH | 3.33 | 22817900 | |
| 322 | Ubiquitination | MLTQMMFEQSPPGSA HHHHHHHHCCCCCCC | 32.05 | 27667366 | |
| 333 | Ubiquitination | PGSATLGSHTKCLEP CCCCCCCCCCCCCHH | 30.97 | 21963094 | |
| 402 | Ubiquitination | DQLQFTEQNLDEALT HHHHHHHCCHHHHHH | 53.37 | 22053931 | |
| 409 | Phosphorylation | QNLDEALTRKKCERI CCHHHHHHHHHHHHH | 47.71 | 20071362 | |
| 430 | Ubiquitination | LLTLCGDDTLKMHIA HHHHHCCHHHHHHHH | 38.94 | 22505724 | |
| 438 | Ubiquitination | TLKMHIAKILTTVKC HHHHHHHHHHHHHCC | 37.33 | 29967540 | |
| 441 | Phosphorylation | MHIAKILTTVKCTTL HHHHHHHHHHCCCHH | 32.77 | - | |
| 442 | Phosphorylation | HIAKILTTVKCTTLI HHHHHHHHHCCCHHH | 17.96 | - | |
| 452 | Ubiquitination | CTTLIEQQFTYGKID CCHHHHHHCCCCEEE | 21.62 | 22505724 | |
| 465 | Ubiquitination | IDLGFGTKVADSELC EEECCCCCCCCHHHH | 35.49 | 29967540 | |
| 470 (in isoform 2) | Ubiquitination | - | 59.75 | 21906983 | |
| 470 | Ubiquitination | GTKVADSELCKLAAD CCCCCCHHHHHHHHH | 59.75 | 22817900 | |
| 473 | Ubiquitination | VADSELCKLAADVIL CCCHHHHHHHHHHHH | 54.51 | 29967540 | |
| 474 | Ubiquitination | ADSELCKLAADVILK CCHHHHHHHHHHHHH | 4.66 | 24816145 | |
| 477 | Ubiquitination | ELCKLAADVILKTLD HHHHHHHHHHHHHHH | 23.53 | 27667366 | |
| 488 | Ubiquitination | KTLDLINKLKPLVPG HHHHHHHHHCCCCCC | 51.39 | 21963094 | |
| 488 (in isoform 2) | Ubiquitination | - | 51.39 | 21906983 | |
| 502 | Ubiquitination | GMEVSFYKILQDPRL CCEEEHHHHHCCCCC | 34.62 | - | |
| 557 | Ubiquitination | IAANNAYRQQETEHI HHHCCHHHHHCCCCC | 29.33 | 22053931 | |
| 567 | Ubiquitination | ETEHIPRKMPWQSSN CCCCCCCCCCCCCCC | 43.91 | 29967540 | |
| 572 | Phosphorylation | PRKMPWQSSNHSFPT CCCCCCCCCCCCCCC | 29.28 | 25159151 | |
| 573 | Phosphorylation | RKMPWQSSNHSFPTS CCCCCCCCCCCCCCC | 24.38 | 25159151 | |
| 576 | Phosphorylation | PWQSSNHSFPTSIKC CCCCCCCCCCCCCHH | 36.85 | 27732954 | |
| 582 | Ubiquitination | HSFPTSIKCLTPHLK CCCCCCCHHCCCHHH | 23.98 | 29967540 | |
| 585 | Phosphorylation | PTSIKCLTPHLKDGV CCCCHHCCCHHHCCC | 20.38 | 23312004 | |
| 588 | Ubiquitination | IKCLTPHLKDGVPGL CHHCCCHHHCCCCCC | 5.95 | 22505724 | |
| 589 | Ubiquitination | KCLTPHLKDGVPGLN HHCCCHHHCCCCCCC | 49.77 | 22505724 | |
| 603 | Ubiquitination | NIEELIEKLQSGMVV CHHHHHHHHHCCCCC | 44.85 | 29967540 | |
| 610 | Ubiquitination | KLQSGMVVKDQICDV HHHCCCCCCCCCCCE | 4.14 | 22505724 | |
| 611 | Ubiquitination | LQSGMVVKDQICDVR HHCCCCCCCCCCCEE | 32.29 | 32015554 | |
| 626 | Phosphorylation | ISDIMDVYEMKLSTL HHHHHHHHHHHHHHH | 13.17 | - | |
| 628 | Ubiquitination | DIMDVYEMKLSTLAS HHHHHHHHHHHHHCC | 2.64 | 22817900 | |
| 629 (in isoform 1) | Ubiquitination | - | 27.61 | 21906983 | |
| 629 | Ubiquitination | IMDVYEMKLSTLASK HHHHHHHHHHHHCCC | 27.61 | 21906983 | |
| 635 | Ubiquitination | MKLSTLASKESRLQD HHHHHHCCCHHHHHH | 39.82 | 27667366 | |
| 636 | Ubiquitination | KLSTLASKESRLQDL HHHHHCCCHHHHHHH | 54.85 | 27667366 | |
| 638 | Phosphorylation | STLASKESRLQDLLE HHHCCCHHHHHHHHH | 41.86 | - | |
| 646 | Ubiquitination | RLQDLLETKALALAQ HHHHHHHHHHHHHHH | 22.91 | 21963094 | |
| 647 (in isoform 1) | Ubiquitination | - | 31.84 | 21906983 | |
| 647 | Ubiquitination | LQDLLETKALALAQA HHHHHHHHHHHHHHH | 31.84 | 21963094 | |
| 656 | Methylation | LALAQADRLIAQHRC HHHHHHHHHHHHHHH | 30.89 | - | |
| 685 | Ubiquitination | MLREVERKNEELSVL HHHHHHHHHHHHHHH | 56.03 | 29967540 | |
| 694 | Ubiquitination | EELSVLLKAQQVESE HHHHHHHHHHHHHHH | 39.73 | 29967540 | |
| 715 | Ubiquitination | EHLFQHNRKLESVAE HHHHHHCHHHHHHHH | 42.69 | 22053931 | |
| 716 | Ubiquitination | HLFQHNRKLESVAEE HHHHHCHHHHHHHHH | 63.02 | 22053931 | |
| 719 | Phosphorylation | QHNRKLESVAEEHEI HHCHHHHHHHHHHHH | 36.74 | 28555341 | |
| 729 | Ubiquitination | EEHEILTKSYMELLQ HHHHHHHHHHHHHHH | 35.82 | 29967540 | |
| 740 | Phosphorylation | ELLQRNESTEKKNKD HHHHCCCCHHHHHCC | 45.47 | 22210691 | |
| 741 | Phosphorylation | LLQRNESTEKKNKDL HHHCCCCHHHHHCCC | 45.72 | 22210691 | |
| 746 | Ubiquitination | ESTEKKNKDLQITCD CCHHHHHCCCHHHHH | 69.56 | - | |
| 751 | Phosphorylation | KNKDLQITCDSLNKQ HHCCCHHHHHHHHHH | 9.41 | 20873877 | |
| 754 | Phosphorylation | DLQITCDSLNKQIET CCHHHHHHHHHHHHH | 35.67 | 20873877 | |
| 761 | Phosphorylation | SLNKQIETVKKLNES HHHHHHHHHHHHHHH | 38.97 | 17192257 | |
| 764 | Acetylation | KQIETVKKLNESLKE HHHHHHHHHHHHHHH | 52.81 | 7822405 | |
| 775 | Ubiquitination | SLKEQNEKSIAQLIE HHHHHHHHHHHHHHH | 55.50 | 29967540 | |
| 783 | Ubiquitination | SIAQLIEKEEQRKEV HHHHHHHHHHHHHHH | 60.60 | 29967540 | |
| 787 | Ubiquitination | LIEKEEQRKEVQNQL HHHHHHHHHHHHHHH | 40.14 | 24816145 | |
| 788 | Ubiquitination | IEKEEQRKEVQNQLV HHHHHHHHHHHHHHH | 63.03 | 24816145 | |
| 800 | Ubiquitination | QLVDREHKLANLHQK HHHHHHHHHHHHHHH | 44.54 | 29967540 | |
| 820 | Acetylation | EKIKTLQKEREDKEE HHHHHHHHHHCCHHH | 62.95 | 20167786 | |
| 828 | Phosphorylation | EREDKEETIDILRKE HHCCHHHHHHHHHHH | 25.66 | 24719451 | |
| 847 | Phosphorylation | EQIRKELSIKASSLE HHHHHHHHHHHHHHH | 24.12 | 23401153 | |
| 857 | Ubiquitination | ASSLEVQKAQLEGRL HHHHHHHHHHHCCCH | 43.19 | 29967540 | |
| 872 | Ubiquitination | EEKESLVKLQQEELN HHHHHHHHHHHHHHH | 45.96 | 32015554 | |
| 890 | Phosphorylation | HMIAMIHSLSGGKIN HHHHHHHHHHCCCCC | 17.19 | 29449344 | |
| 892 | Phosphorylation | IAMIHSLSGGKINPE HHHHHHHHCCCCCHH | 48.81 | 29449344 | |
| 900 | Phosphorylation | GGKINPETVNLSI-- CCCCCHHHCCCCC-- | 18.89 | 27251275 | |
| 904 | Phosphorylation | NPETVNLSI------ CHHHCCCCC------ | 22.50 | 25159151 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CIP2A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CIP2A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| 2AAA_HUMAN | PPP2R1A | physical | 17632056 | |
| MYC_HUMAN | MYC | physical | 17632056 | |
| EGFR_HUMAN | EGFR | physical | 23956138 | |
| CHIP_HUMAN | STUB1 | physical | 24293411 | |
| STOM_HUMAN | STOM | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-761 AND SER-904, ANDMASS SPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-904, AND MASSSPECTROMETRY. | |